Works matching DE "PROSTATE cancer %26 genetics"

Results: 495

Enhancing chemotherapy efficacy by reprogramming the senescence-associated secretory phenotype of prostate tumors.

Published in:

OncoImmunology, 2015, v. 4, n. 3, p. 00, doi. 10.4161/2162402X.2014.994380

By:

Toso, Alberto;
Di Mitri, Diletta;
Alimonti, Andrea

Publication type:

Article

Overexpression of Cdc20 in clinically localized prostate cancer: Relation to high Gleason score and biochemical recurrence after laparoscopic radical prostatectomy.

Published in:

Cancer Biomarkers, 2016, v. 16, n. 3, p. 351, doi. 10.3233/CBM-160573

By:

Yunhua Mao;
Ke Li;
Li Lu;
Jie Si-tu;
Minhua Lu;
Xin Gao

Publication type:

Article

contamDE: differential expression analysis of RNA-seq data for contaminated tumor samples.

Published in:

Bioinformatics, 2016, v. 32, n. 5, p. 705, doi. 10.1093/bioinformatics/btv657

By:

Qi Shen;
Jiyuan Hu;
Ning Jiang;
Xiaohua Hu;
Zewei Luo;
Hong Zhang

Publication type:

Article

Reference-free prediction of rearrangement breakpoint reads.

Published in:

Bioinformatics, 2014, v. 30, n. 18, p. 2559, doi. 10.1093/bioinformatics/btu360

By:

Wijaya, Edward;
Shimizu, Kana;
Asai, Kiyoshi;
Hamada, Michiaki

Publication type:

Article

Integrative gene network construction for predicting a set of complementary prostate cancer genes.

Published in:

Bioinformatics, 2011, v. 27, n. 13, p. 1846, doi. 10.1093/bioinformatics/btr283

By:

Ahn, Jaegyoon;
Yoon, Youngmi;
Park, Chihyun;
Shin, Eunji;
Park, Sanghyun

Publication type:

Article

Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target.

Published in:

Journal of Clinical Medicine, 2018, v. 7, n. 6, p. 156, doi. 10.3390/jcm7060156

By:

Salgia, Ravi;
Jolly, Mohit Kumar;
Dorff, Tanya;
Lau, Clayton;
Weninger, Keith;
Orban, John;
Kulkarni, Prakash

Publication type:

Article

Repression of Micro RNA-372 by Arsenic Sulphide Inhibits Prostate Cancer Cell Proliferation and Migration through Regulation of large tumour suppressor kinase 2.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2017, v. 120, n. 3, p. 256, doi. 10.1111/bcpt.12687

By:

Cao, Hongwen;
Feng, Yigeng;
Chen, Lei

Publication type:

Article

Investigating the role of caveolin-2 in prostate cancer cell line.

Published in:

AIMS Molecular Science, 2017, v. 4, n. 1, p. 82, doi. 10.3934/molsci.2017.1.82

By:

Jin-Yih Low;
Nicholson, Helen D.

Publication type:

Article

Evaluation of Oxidative Stress Response Related Genetic Variants, Prooxidants, Antioxidants and Prostate Cancer.

Published in:

AIMS Medical Science, 2015, v. 2, n. 4, p. 271, doi. 10.3934/medsci.2015.4.271

By:

Lavender, Nicole;
Hein, David W.;
Brock, Guy;
Kidd, La Creis R.

Publication type:

Article

Genome-Wide Association Scan for Variants Associated with Early-Onset Prostate Cancer in Romania.

Published in:

Medicina Moderna, 2016, v. 23, n. 2, p. 143

By:

Radavoi, George Daniel;
Iordache, Paul Daniel;
Radoi, Viorica;
Ursu, Radu Ioan;
Rascu, Stefan;
Sima, Cristian;
Vargau, Marian;
Cheorpeaca, Bogdan;
Mischianu, Dan

Publication type:

Article

A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 4, p. 370, doi. 10.1038/pcan.2015.40

By:

Donovan, M J;
Noerholm, M;
Bentink, S;
Belzer, S;
Skog, J;
O'Neill, V;
Cochran, J S;
Brown, G A

Publication type:

Article

Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance.

Published in:

Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 4, p. 325, doi. 10.1038/pcan.2015.39

By:

Martin, A M;
Nirschl, T R;
Nirschl, C J;
Francica, B J;
Kochel, C M;
van Bokhoven, A;
Meeker, A K;
Lucia, M S;
Anders, R A;
DeMarzo, A M;
Drake, C G

Publication type:

Article

Polymorphisms at long non-coding RNAs and prostate cancer risk in an eastern Chinese population.

Published in:

Prostate Cancer & Prostatic Diseases, 2014, v. 17, n. 4, p. 315, doi. 10.1038/pcan.2014.34

By:

Cao, D-L;
Gu, C-Y;
Zhu, Y;
Dai, B;
Zhang, H-L;
Shi, G-H;
Shen, Y-J;
Zhu, Y-P;
Ma, C-G;
Xiao, W-J;
Qin, X-J;
Lin, G-W;
Ye, D-W

Publication type:

Article

SOX2 expression in the developing, adult, as well as, diseased prostate.

Published in:

Prostate Cancer & Prostatic Diseases, 2014, v. 17, n. 4, p. 301, doi. 10.1038/pcan.2014.29

By:

Yu, X;
Cates, J M;
Morrissey, C;
You, C;
Grabowska, M M;
Zhang, J;
DeGraff, D J;
Strand, D W;
Franco, O E;
Lin-Tsai, O;
Hayward, S W;
Matusik, R J

Publication type:

Article

Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population.

Published in:

Prostate Cancer & Prostatic Diseases, 2014, v. 17, n. 2, p. 149, doi. 10.1038/pcan.2014.1

By:

Oh, J J;
Byun, S-S;
Lee, S E;
Hong, S K;
Jeong, C W;
Choi, W S;
Kim, D;
Kim, H J;
Myung, S C

Publication type:

Article

Prostate cancer susceptibility genes on 8p21-23 in a Dutch population.

Published in:

Prostate Cancer & Prostatic Diseases, 2013, v. 16, n. 3, p. 248, doi. 10.1038/pcan.2013.9

By:

Zeegers, M P;
Nekeman, D;
Khan, H S;
van Dijk, B A C;
Goldbohm, R A;
Schalken, J;
Shajahan, S;
Pearlman, A;
Oddoux, C;
van den Brandt, P A;
Schouten, L J;
Ostrer, H

Publication type:

Article

Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.

Published in:

Prostate Cancer & Prostatic Diseases, 2013, v. 16, n. 4, p. 315, doi. 10.1038/pcan.2013.38

By:

Chiu, S C;
Huang, S Y;
Chen, S P;
Su, C C;
Chiu, T L;
Pang, C Y

Publication type:

Article

BRCA1 and p53 regulate critical prostate cancer pathways.

Published in:

Prostate Cancer & Prostatic Diseases, 2013, v. 16, n. 3, p. 233, doi. 10.1038/pcan.2013.12

By:

De Luca, P;
Moiola, C P;
Zalazar, F;
Gardner, K;
Vazquez, E S;
De Siervi, A

Publication type:

Article

Prostate-specific membrane antigen (FOLH1): recent advances in characterising this putative prostate cancer gene.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 4, p. 180, doi. 10.1038/sj.pcan.4500325

By:

Maraj, B H;
Markham, A F

Publication type:

Article

Allelic losses at 8p, 10q, 11p, 13q, 16q, 17p, and 18q in prostatic carcinomas: The impact of zonal location, Gleason grade, and tumour multifocality.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 4, p. 204, doi. 10.1038/sj.pcan.4500324

By:

Erbersdobler, A;
Graefen, M;
Wullbrand, A;
Hammerer, P;
Henke, R-P

Publication type:

Article

Pathologic progression of autochthonous prostate cancer in the TRAMP model.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 70, doi. 10.1038/sj.pcan.4500296

By:

Gingrich, J R;
Barrios, R J;
Foster, B A;
Greenberg, N M

Publication type:

Article

Cytotoxic Activity and Quantitative Structure Activity Relationships of Arylpropyl Sulfonamides.

Published in:

Korean Journal of Physiology & Pharmacology, 2013, v. 17, n. 3, p. 237, doi. 10.4196/kjpp.2013.17.3.237

By:

Yu Jin Hwang;
Sang Min Park,;
Chul Bu Yim;
Chaeuk Im

Publication type:

Article

Downregulation of lncRNA PVT1 expression inhibits proliferation and migration by regulating p38 expression in prostate cancer.

Published in:

Oncology Letters, 2018, v. 16, n. 4, p. 5160, doi. 10.3892/ol.2018.9305

By:

Wan, Bo;
Wu, Hua-Yan;
Lv, Dao-Jun;
Zhou, Xu-Min;
Zhong, Li-Ren;
Lei, Bin;
Zhang, Shou-Bo;
Mao, Xiang-Ming

Publication type:

Article

Identification of genes that predict the biochemical recurrence of prostate cancer.

Published in:

Oncology Letters, 2018, v. 16, n. 3, p. 3447, doi. 10.3892/ol.2018.9106

By:

Chu, JianfENg;
Li, Ning;
Gai, WENtao

Publication type:

Article

Expression of miR-30c and miR-29b in prostate cancer and its diagnostic significance.

Published in:

Oncology Letters, 2018, v. 16, n. 3, p. 3140, doi. 10.3892/ol.2018.9007

By:

Zhu, Chuanan;
Hou, Xiumei;
Zhu, Jiabin;
Jiang, Chunxiao;
Wei, Wei

Publication type:

Article

Overexpression of TPX2 is associated with progression and prognosis of prostate cancer.

Published in:

Oncology Letters, 2018, v. 16, n. 3, p. 2823, doi. 10.3892/ol.2018.9016

By:

Zou, Jun;
Huang, Rui-Yan;
Jiang, Fu-NENg;
ChEN, De-Xiong;
Wang, Cong;
Han, Zhao-Dong;
Liang, Yu-Xiang;
Zhong, Wei-De

Publication type:

Article

Prostate cancer cell proliferation is suppressed by microRNA‑3160‑5p via targeting of F‑box and WD repeat domain containing 8.

Published in:

Oncology Letters, 2018, v. 15, n. 6, p. 9436, doi. 10.3892/ol.2018.8505

By:

Lin, Ping;
Zhu, Lijuan;
Sun, WENjing;
Yang, ZhENgkai;
Sun, Hui;
Li, Dong;
Cui, Rongjun;
ZhENg, Xiulan;
Yu, Xiaoguang

Publication type:

Article

Knockdown of spindle pole body component 25 homolog inhibits cell proliferation and cycle progression in prostate cancer.

Published in:

Oncology Letters, 2018, v. 15, n. 4, p. 5712, doi. 10.3892/ol.2018.8003

By:

Cui, Feilun;
Hu, Jianpeng;
Fan, Yu;
Tan, Jian;
Tang, Huaming

Publication type:

Article

Identification of potential key genes and high-frequency mutant genes in prostate cancer by using RNA-Seq data.

Published in:

Oncology Letters, 2018, v. 15, n. 4, p. 4550, doi. 10.3892/ol.2018.7846

By:

Zhang, Ze;
Wu, He;
Zhou, Hong;
Gu, Yunhe;
Bai, Yufeng;
Yu, Shiliang;
An, Ruihua;
Qi, Jiping

Publication type:

Article

Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC‑3 cells via an AKR1C3 mechanism.

Published in:

Oncology Letters, 2018, v. 15, n. 3, p. 3167, doi. 10.3892/ol.2017.7721

By:

Sekine, Yoshitaka;
Nakayama, Hiroshi;
Miyazawa, Yoshiyuki;
Kato, Haruo;
Furuya, Yosuke;
Arai, Seiji;
Koike, Hidekazu;
Matsui, Hiroshi;
Shibata, Yasuhiro;
Ito, Kazuto;
Suzuki, Kazuhiro

Publication type:

Article

Prostate stem cell antigen is expressed in normal and malignant human brain tissues.

Published in:

Oncology Letters, 2018, v. 15, n. 3, p. 3081, doi. 10.3892/ol.2017.7632

By:

Ono, Hiroe;
Sakamoto, Hiromi;
Yoshida, Teruhiko;
Saeki, Norihisa

Publication type:

Article

NAC1 promotes the migration of prostate cancer cells and participates in osteoclastogenesis by negatively regulating IFNβ.

Published in:

Oncology Letters, 2018, v. 15, n. 3, p. 2921, doi. 10.3892/ol.2017.7670

By:

ChEN, Fang;
Yin, Yinghao;
Yan, ZhifENg;
Cao, Ke;
Zhong, Kuangbiao

Publication type:

Article

Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cells.

Published in:

Oncology Letters, 2018, v. 15, n. 3, p. 2871, doi. 10.3892/ol.2017.7664

By:

Liu, Yongqing;
Yue, ChunwEN;
Li, Juan;
Wu, Jing;
Wang, Shikang;
Sun, Deqing;
Guo, Yanxia;
Lin, Zhaomin;
Zhang, DENglu;
Wang, Rongmei

Publication type:

Article

Validation of the novel susceptibility loci for prostate cancer in a Chinese population.

Published in:

Oncology Letters, 2018, v. 15, n. 2, p. 2567, doi. 10.3892/ol.2017.7602

By:

Wu, Yishuo;
Chen, Haitao;
Ji, Ying;
Na, Rong;
Mo, Zengnan;
Ye, Dingwei;
Wang, Meilin;
Qi, Jun;
Lin, Xiaoling;
Ding, Qiang;
Xu, Jianfeng;
Zheng, S. Lilly;
Sun, Yinghao;
Meng, Wei

Publication type:

Article

Increased expression of tumor protein D54 is associated with clinical progression and poor prognosis in patients with prostate cancer.

Published in:

Oncology Letters, 2017, v. 14, n. 6, p. 7739, doi. 10.3892/ol.2017.7214

By:

Ligang Ren;
Jing Chen;
Xinnan Zhang

Publication type:

Article

Stability analysis on the radioactive iodine‑labelled prostate cancer‑specific recombinant oncolytic adenovirus.

Published in:

Oncology Letters, 2017, v. 14, n. 6, p. 6403, doi. 10.3892/ol.2017.6998

By:

Jiahe Zhou;
Lin Hao;
Zhenduo Shi;
Songyi Ning;
Houguang He;
Yan Zhao;
Yang Dong;
Zhigang Li;
Jiuxiang He;
Guanghui Zang;
Conghui Han

Publication type:

Article

SHISA2 enhances the aggressive phenotype in prostate cancer through the regulation of WNT5A expression.

Published in:

Oncology Letters, 2017, v. 14, n. 6, p. 6650, doi. 10.3892/ol.2017.7099

By:

Kenji Tamura;
Mutsuo Furihata;
Hirofumi Satake;
Hatsune Hashida;
Chiaki Kawada;
Hiroto Osakabe;
Hideo Fukuhara;
Naoko Kumagai;
Tatsuo Iiyama;
Taro Shuin;
Keiji Inoue

Publication type:

Article

The context of prostate cancer genomics in personalized medicine (Review).

Published in:

Oncology Letters, 2017, v. 13, n. 5, p. 3347, doi. 10.3892/ol.2017.5911

By:

YANLING LIU

Publication type:

Article

Liposome-mediated transfection of wild-type P53 DNA into human prostate cancer cells is improved by low-frequency ultrasound combined with microbubbles.

Published in:

Oncology Letters, 2016, v. 11, n. 6, p. 3829, doi. 10.3892/ol.2016.4477

By:

WEN-KUN BAI;
WEI ZHANG;
BING HU;
TAO YING

Publication type:

Article

ERG rearrangement as a novel marker for predicting the extra-prostatic extension of clinically localised prostate cancer.

Published in:

Oncology Letters, 2016, v. 11, n. 4, p. 2532, doi. 10.3892/ol.2016.4282

By:

LI LU;
HAO ZHANG;
JUN PANG;
GUO-LIANG HOU;
MIN-HUA LU;
XIN GAO

Publication type:

Article

Hepatocyte growth factor increases the invasive potential of PC-3 human prostate cancer cells via an ERK/MAPK and Zeb-1 signaling pathway.

Published in:

Oncology Letters, 2016, v. 11, n. 1, p. 753, doi. 10.3892/ol.2015.3943

By:

YILI HAN;
YONG LUO;
YONGXING WANG;
YATONG CHEN;
MINGCHUAN LI;
YONGGUANG JIANG

Publication type:

Article

Signal transduction by M3 muscarinic acetylcholine receptor in prostate cancer.

Published in:

Oncology Letters, 2016, v. 11, n. 1, p. 385, doi. 10.3892/ol.2015.3830

By:

LIQIANG GUO;
YUQIANG LIU;
ZHIBO DING;
WENDONG SUN;
MINGZHEN YUAN

Publication type:

Article

Decreased expression of ferroportin in prostate cancer.

Published in:

Oncology Letters, 2015, v. 10, n. 2, p. 913, doi. 10.3892/ol.2015.3363

By:

DONG XUE;
CUI-XING ZHOU;
YUN-BO SHI;
HAO LU;
XIAO-ZHOU HE

Publication type:

Article

Nicotinamide N-methyltransferase is overexpressed in prostate cancer and correlates with prolonged progression-free and overall survival times.

Published in:

Oncology Letters, 2014, v. 8, n. 3, p. 1175, doi. 10.3892/ol.2014.2287

By:

WEIMIN ZHOU;
MING GUI;
MIN ZHU;
ZHI LONG;
LIHUA HUANG;
JUN ZHOU;
LEYE HE;
KUANGBIAO ZHONG

Publication type:

Article

Immunohistochemical expression of four different stem cell markers in prostate cancer: High expression of NANOG in conjunction with hypoxia-inducible factor-1α expression is involved in prostate epithelial malignancy.

Published in:

Oncology Letters, 2014, v. 8, n. 3, p. 985, doi. 10.3892/ol.2014.2274

By:

KATSUHITO MIYAZAWA;
TAKUJI TANAKA;
DAN NAKAI;
NOBUYO MORITA;
KOJI SUZUKI

Publication type:

Article

Expression profiling of stem cell signaling alters with spheroid formation in CD133<sup>high</sup>/CD44<sup>high</sup> prostate cancer stem cells.

Published in:

Oncology Letters, 2014, v. 7, n. 6, p. 2103, doi. 10.3892/ol.2014.1992

By:

OKTEM, GULPERI;
BILIR, AYHAN;
USLU, RUCHAN;
INAN, SEVINC V.;
DEMIRAY, SIRIN B.;
ATMACA, HARIKA;
AYLA, SULE;
SERCAN, OGUN;
UYSAL, AYSEGUL

Publication type:

Article

Related to testes-specific, vespid and pathogenesis protein-1 is regulated by methylation in glioblastoma.

Published in:

Oncology Letters, 2014, v. 7, n. 4, p. 1209, doi. 10.3892/ol.2014.1829

By:

JACOBY, ELAD;
YALON, MICHAL;
LEITNER, MOSHE;
COHEN, ZVI R.;
COHEN, YEHUDIT;
FISHER, TAMAR;
EDER, SARIT;
AMARIGLIO, NINETTE;
RECHAVI, GIDEON;
CAZACU, SIMONA;
XIANG, CUNLI;
MIKKELSEN, TOM;
BRODIE, CHAYA;
TOREN, AMOS

Publication type:

Article

Evaluation of a 3-base pair indel polymorphism within pre-microRNA-3131 in patients with prostate cancer using mismatch polymerase chain reaction-restriction fragment length polymorphism.

Published in:

Molecular & Clinical Oncology, 2017, v. 7, n. 4, p. 696, doi. 10.3892/mco.2017.1369

By:

HASHEMI, MOHAMMAD;
BAHARI, GHOLAMREZA;
SATTARIFARD, HEDIEH;
NAROUIE, BEHZAD

Publication type:

Article

Combination of real-time elastography and urine prostate cancer gene 3 (PCA3) detects more than 97% of significant prostate cancers.

Published in:

Scandinavian Journal of Urology (Taylor & Francis Ltd), 2013, v. 47, n. 3, p. 211, doi. 10.3109/00365599.2012.727859

By:

Nygård, Yngve;
Haukaas, Svein A.;
Waage, Jo E. R.;
Halvorsen, Ole J.;
Gravdal, Karsten;
Frugård, Jannicke;
Akslen, Lars A.;
Beisland, Christian

Publication type:

Article

Family history of prostate cancer and age‐related trend of testosterone levels among US males: NHANES 2003–2004.

Published in:

Andrology, 2019, v. 7, n. 3, p. 288, doi. 10.1111/andr.12609

By:

Zhang, X.;
Zhong, Y.;
Taylor, N.;
Xu, X.

Publication type:

Article